LXEO — LEXEO THERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 151 家机构在其最新 13F 申报中持有 LXEO(LEXEO THERAPEUTICS INC),合计申报市值 $414.84M,对应 89.15M 股。按股数计算较上季度增持 23.5%(+15.64M 股),申报市值环比上升 0.1%。持仓集中度较高:前五大持有人占申报市值的 31.1%,前十大的集中度为 53.9%。
与上一季度相比,29 家新建仓位、62 家加仓、41 家减仓、24 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
LEXEO THERAPEUTICS INC(LXEO)的主要机构持有人包括 SABBY MANAGEMENT, LLC、Vanguard Group、MONTANOVA CAPITAL, LLC,按 13F 申报市值在本页 248 家持有人中排名居前。
LXEO 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 96 | 38.15M | $129.13M | +19.8% |
| Q2 2026 | 151 | 89.15M | $414.84M | +23.5% |
| Q1 2026 | 146 | 78.39M | $449.87M | +2.9% |
| Q4 2025 | 151 | 78.41M | $778.19M | +12.5% |
| Q3 2025 | 114 | 52.10M | $345.84M | +15.3% |
| Q2 2025 | 96 | 45.34M | $182.31M | +72.4% |
| Q1 2025 | 88 | 26.39M | $94.35M | -13.3% |
| Q4 2024 | 91 | 29.77M | $195.75M | -0.5% |
表内 8 个季度中,机构持股合计增加 28%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2025(+72.4%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 7.25M | $24.49M | 1.14% | 增持 | |
| 5.97M | $20.19M | 0.00% | 增持 | |
| 4.58M | $15.67M | 0.00% | 增持 | |
| 3.59M | $12.15M | 0.00% | 增持 | |
| 3.19M | $10.77M | 0.00% | 增持 | |
| 1.43M | $4.83M | 0.00% | 减持 | |
| 1.30M | $4.39M | 0.20% | 持有 | |
| 1.29M | $4.35M | 0.01% | 增持 | |
| 1.19M | $4.03M | 0.00% | 减持 | |
| 969.15K | $3.28M | 0.01% | 减持 | |
| 928.59K | $3.14M | 0.50% | 持有 | |
| 593.74K | $2.01M | 0.34% | 新进 | |
| 482.91K | $1.63M | 0.00% | 减持 | |
| 477.98K | $1.62M | 0.00% | 增持 | |
| 403.06K | $1.36M | 0.00% | 增持 | |
| 371.52K | $1.26M | 0.00% | 增持 | |
| 370.84K | $1.25M | 0.00% | 减持 | |
| 351.62K | $1.19M | 0.00% | 减持 | |
| 307.37K | $1.04M | 0.01% | 新进 | |
| 248.40K | $839.60K | 0.00% | 新进 | |
| 235.15K | $794.82K | 0.00% | 增持 | |
| 178.54K | $603.48K | 0.00% | 减持 | |
| 177.25K | $599.11K | 0.00% | 增持 | |
| 157.16K | $531.19K | 0.00% | 减持 | |
| 155.00K | $523.90K | 0.10% | 持有 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 6.11M | $40.49M | 0.02% | 增持 | |
| 4.42M | $29.38M | 0.88% | 持有 | |
| 3.91M | $25.99M | 0.09% | 减持 | |
| 3.87M | $25.70M | 2.48% | 增持 | |
| 3.72M | $24.69M | 0.04% | 增持 | |
| 3.25M | $21.58M | 0.97% | 增持 | |
| 2.57M | $17.08M | 0.08% | 持有 | |
| 2.31M | $15.36M | 0.03% | 减持 | |
| 2.31M | $15.36M | 0.01% | 减持 | |
| 2.23M | $14.78M | 0.00% | 增持 | |
| 2.17M | $14.42M | 0.00% | 增持 | |
| 1.94M | $12.89M | 0.05% | 增持 | |
| 1.53M | $10.17M | 1.04% | 增持 | |
| 1.12M | $7.47M | 0.03% | 持有 | |
| 978.65K | $6.50M | 0.07% | 持有 | |
| 922.66K | $6.13M | 0.38% | 新进 | |
| 912.53K | $6.06M | 0.00% | 增持 | |
| 778.61K | $5.17M | 0.73% | 新进 | |
| 721.88K | $4.79M | 0.00% | 增持 | |
| 603.43K | $4.01M | 0.16% | 持有 | |
| 567.60K | $3.77M | 0.60% | 增持 | |
| 544.85K | $3.62M | 0.00% | 增持 | |
| 414.86K | $2.75M | 0.02% | 持有 | |
| 358.08K | $2.38M | 0.60% | 减持 | |
| 347.92K | $2.31M | 0.00% | 增持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.42M | $17.79M | 0.71% | 增持 | |
| 4.01M | $16.12M | 0.06% | 新进 | |
| 3.68M | $14.83M | 0.01% | 减持 | |
| 3.61M | $14.50M | 0.03% | 增持 | |
| 3.59M | $14.43M | 2.23% | 增持 | |
| 3.23M | $12.98M | 0.68% | 增持 | |
| 2.84M | $11.40M | 0.02% | 增持 | |
| 2.84M | $11.40M | 0.01% | 增持 | |
| 2.57M | $10.34M | 0.06% | 增持 | |
| 2.00M | $8.05M | 0.00% | 增持 | |
| 1.83M | $7.35M | 0.00% | 减持 | |
| 1.18M | $4.76M | 3.08% | 持有 | |
| 1.12M | $4.52M | 0.02% | 减持 | |
| 978.65K | $3.93M | 0.06% | 持有 | |
| 867.30K | $3.49M | 2.90% | 新进 | |
| 647.88K | $2.60M | 0.01% | 减持 | |
| 603.43K | $2.43M | 0.13% | 持有 | |
| 578.08K | $2.32M | 0.00% | 减持 | |
| 550.03K | $2.21M | 0.72% | 持有 | |
| 513.03K | $2.06M | 0.00% | 增持 | |
| 414.86K | $1.67M | 0.01% | 持有 | |
| 378.08K | $1.52M | 0.43% | 持有 | |
| 271.90K | $1.09M | 0.00% | 增持 | |
| 200.79K | $807.16K | 0.00% | 减持 | |
| 188.63K | $758.31K | 0.00% | 增持 |
新建仓(Q2 2026)
- Jupiter Topco LLC 3.95M 股 · $18.41M
- GEODE CAPITAL MANAGEMENT, LLC 1.75M 股 · $8.14M
- Trexquant Investment LP 314.89K 股 · $1.47M
- Renaissance Technologies 250.37K 股 · $1.17M
- Sixth Street Partners Management Company, L.P. 172.61K 股 · $803.50K
- Palumbo Wealth Management LLC 114.74K 股 · $534.13K
- Fisher Asset Management, LLC 114.32K 股 · $532.17K
- Walleye Capital LLC 73.87K 股 · $343.86K
- STATE OF WISCONSIN INVESTMENT BOARD 48.32K 股 · $224.95K
- Dynamic Technology Lab Private Ltd 32.65K 股 · $152.00K
- Verdad Advisers, LP 30.59K 股 · $142.40K
- Quantinno Capital Management LP 24.29K 股 · $113.08K
完全清仓(较上季)
- Janus Henderson Group 卖出 4.98M 股 · $28.51M
- STATE STREET CORP 卖出 3.57M 股 · $20.48M
- Point72 Asset Management 卖出 1.68M 股 · $9.65M
- Octagon Capital Advisors LP 卖出 1.10M 股 · $6.31M
- Two Sigma Investments 卖出 181.68K 股 · $1.04M
- Y-Intercept (Hong Kong) Ltd 卖出 142.57K 股 · $818.36K
- Bleakley Financial Group, LLC 卖出 47.96K 股 · $275.31K
- GSA CAPITAL PARTNERS LLP 卖出 34.27K 股 · $197.00K
- PANAGORA ASSET MANAGEMENT INC 卖出 34.30K 股 · $196.87K
- AXQ CAPITAL, LP 卖出 26.12K 股 · $149.92K
- Schonfeld Strategic Advisors LLC 卖出 24.22K 股 · $139.03K
- CWM, LLC 卖出 18.32K 股 · $105.14K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Affinity Asset Advisors, LLC | 7.25M | 5.81M | 5.05M | 3.20M | 3.87M | 3.59M | 1.48M | — | — | — | — | — |
| BlackRock Inc | 5.97M | 5.74M | 5.11M | 4.91M | 2.17M | 1.83M | 1.84M | 1.82M | 1.63M | — | — | — |
| JPMorgan Chase & Co | 4.58M | 96.29K | 93.16K | 29.86K | 14.36K | 13.75K | 13.78K | 13.37K | 10.28K | 4.36K | 5.95K | 112 |
| STATE STREET CORP | 3.59M | — | 3.57M | 3.19M | 544.85K | 513.03K | 469.73K | 457.40K | 253.95K | 196.27K | 112.22K | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.19M | 3.13M | 3.01M | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 1.43M | 1.75M | 1.51M | 1.45M | 721.88K | 578.08K | 586.52K | 567.38K | 553.25K | 296.61K | 197.80K | 100.42K |
| Nantahala Capital Management, LLC | 1.30M | 1.30M | 1.20M | 1.00M | — | — | — | — | — | — | — | — |
| Aberdeen Group plc | 1.29M | 675.09K | 245.90K | — | — | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 1.19M | 1.29M | 1.10M | 862.89K | 912.53K | 47.02K | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 969.15K | 1.38M | 465.51K | 133.26K | — | — | — | — | — | — | — | 603 |
| Spruce Street Capital LP | 928.59K | 928.59K | 928.59K | 175.00K | — | — | — | — | — | — | — | — |
| Jones Hill Capital LP | 593.74K | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 482.91K | 613.83K | 577.19K | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 477.98K | 430.70K | 384.73K | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 403.06K | 141.15K | 24.39K | 13.39K | 13.43K | 11.75K | 9.86K | 2.00K | 595 | 135 | 13 | — |
| Renaissance Technologies | 371.52K | 250.37K | — | 217.77K | 149.30K | 106.20K | 20.30K | — | — | — | 14.58K | — |
| BNP PARIBAS FINANCIAL MARKETS | 370.84K | 388.40K | 228.20K | 257.42K | 30.73K | 48.43K | 40.21K | 34.53K | 5.54K | 1.95K | 4.78K | — |
| UBS Group AG | 351.62K | 354.04K | 321.74K | 281.08K | 249.91K | 271.90K | 32.08K | 51.05K | 11.11K | 3.13K | 10.37K | — |
| Verition Fund Management LLC | 307.37K | — | — | 428.46K | 414.86K | 414.86K | 414.86K | 709.90K | 777.32K | 421.39K | 60.84K | 189.06K |
| Marshall Wace | 248.40K | — | — | — | — | — | 81.01K | 17.79K | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold LXEO?
As of 2026-Q2, 151 institutional funds reported holding LXEO (LEXEO THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $414.84M.
How many shares of LXEO do institutions own?
13F filers reported 89.15M shares of LXEO, worth $414.84M in aggregate at the end of 2026-Q2.
Is institutional ownership of LXEO rising or falling?
Share counts moved +23.5% versus the prior quarter — accumulation.
Who are the top institutional holders of LXEO?
The largest 13F holders are SABBY MANAGEMENT, LLC, Vanguard Group, MONTANOVA CAPITAL, LLC, Janus Henderson Group, Affinity Asset Advisors, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of LEXEO THERAPEUTICS INC?
The major shareholders of LEXEO THERAPEUTICS INC (LXEO) by reported 13F value are SABBY MANAGEMENT, LLC, Vanguard Group, MONTANOVA CAPITAL, LLC, Janus Henderson Group, Affinity Asset Advisors, LLC, among 248 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.